Hutch News

Hutch News

Stories tagged 'tumor'

Investigational urine test can predict aggressive prostate cancer

Daniel Lin study shows two biomarkers in urine are associated with cancers likely to be aggressive among men who take a 'watchful waiting' approach

Feb. 6, 2012 | By Kristen Woodward

Initial results of a multicenter study coordinated by Hutchinson Center researchers indicates that two investigational urine-based biomarkers are associated with prostate cancers that are likely to be aggressive and potentially life-threatening among men who take a "watchful waiting," or active-surveillance, approach to manage their disease. Ultimately, these markers may lead to the development of a urine test that could complement prostate biopsy for predicting disease aggressiveness and progression.

View story >


Greenberg receives immunotherapy award

Clinical Research Division's Philip Greenberg honored for pioneering work to bring adoptive T-cell therapy from bench to bedside

Sept. 26, 2011

Dr. Philip Greenberg, head of the Fred Hutchinson Cancer Research Center’s Immunology Program in the Clinical Research Division, is the joint recipient of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology for his pioneering research in adoptive T-cell therapy.

View story >


Kuni Scholar award paves way for breakthrough research

Medical scientist Maria Corinna Palanca-Wessels, working to defeat ovarian cancer, is among three Pacific Northwest scientists in the inaugural class of Kuni Scholars

July 11, 2011 | By Kristen Woodward

Dr. Maria Corinna Palanca-Wessels of the Fred Hutchinson Cancer Research Center is one step closer to her goal of making ovarian tumors more susceptible to chemotherapy thanks to a two-year, $200,000 award from the Wayne D. Kuni and Joan E. Kuni Foundation of Vancouver, Wash., and the Kuni family (through the 3725 Fund of the Oregon Community Foundation).

View story >


New squamous cell carcinoma drug target discovered

Vasioukhin and colleagues find alpha-catenin protein acts as a tumor suppressor, cell growth control mechanism revealed

May 30, 2011 | By Kristen Woodward

Hutchinson Center researchers have discovered a new drug target for squamous cell carcinoma, the second most common form of skin cancer. Scientists in the Human Biology Division laboratory of Dr. Valeri Vasioukhin found a protein called alpha-catenin acts as a tumor suppressor and they also have unlocked the mechanism by which this protein controls cell proliferation.

View story >


Researchers identify genes that signal oral cancer spread

Discovery could lead to the development of a biomarker-based test in lieu of neck surgery

May 9, 2011 | By Dean Forbes

For the first time, Fred Hutchinson Cancer Research Center scientists have identified genes that signal when oral cancer has spread to lymph nodes in the neck. If confirmed by additional research, the discovery of this four-gene set could lead to the development of a biomarker-based test of the tumor that could help physicians determine whether oral squamous cell carcinoma has spread and therefore become more deadly. The findings appear in the April 15 issue of Clinical Cancer Research.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.